The Chicago Entrepreneur

FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease

The FDA’s approval requires Biogen to further study its ALS drug tofersen to further verify its clinical benefits.

Previous post UPS shares fall after delivery giant reports disappointing earnings
Next post Biogen isn’t concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says